Assays of ADAMTS-13 activity

Pimanda, 2002, Control of von Willebrand factor multimer size and implications for disease, Blood Rev, 16, 185, 10.1016/S0268-960X(02)00017-6

Siedlecki, 1996, Shear-dependent changes in the three-dimensional structure of human von Willebrand factor, Blood, 88, 2939, 10.1182/blood.V88.8.2939.bloodjournal8882939

Tsai, 1994, Shear stress enhances the proteolysis of von Willebrand factor in normal plasma, Blood, 83, 2171, 10.1182/blood.V83.8.2171.2171

Furlan, 1996, Partial purification and characterization of a protease from human plasma cleaving von Willebrand factor to fragments produced by in vivo proteolysis, Blood, 87, 4223, 10.1182/blood.V87.10.4223.bloodjournal87104223

Tsai, 1996, Physiologic cleavage of von Willebrand factor by a plasma protease is dependent on its conformation and requires calcium ion, Blood, 87, 4235, 10.1182/blood.V87.10.4235.bloodjournal87104235

Lyons, 1992, Impaired intracellular transport produced by a subset of type-IIA von Willebrand disease mutations, J Biol Chem, 267, 4424, 10.1016/S0021-9258(18)42852-9

Tsai, 1997, Proteolytic cleavage of recombinant type 2A von Willebrand factor mutants R834W and R834Q, Blood, 89, 1954, 10.1182/blood.V89.6.1954

Lankhof, 1999, Recombinant vWF type 2A mutants R834Q and R834W show a defect in mediating platelet adhesion to collagen, independent of enhanced sensitivity to a plasma protease, Thromb Haemost, 81, 976, 10.1055/s-0037-1614609

Zheng, 2001, Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura, J Biol Chem, 276, 41059, 10.1074/jbc.C100515200

Furlan, 1997, Deficient activity of von Willebrand factor-cleaving protease in chronic relapsing thrombotic thrombocytopenic purpura, Blood, 89, 3097, 10.1182/blood.V89.9.3097

Allford, 2000, von Willebrand factor-cleaving protease activity in congenital thrombotic thrombocytopenic purpura, Br J Haematol, 111, 1215, 10.1046/j.1365-2141.2000.02503.x

van der Plas, 1999, von Willebrand factor proteolysis is deficient in classic, but not in bone marrow transplantation-associated, thrombotic thrombocytopenic purpura, Blood, 93, 3798, 10.1182/blood.V93.11.3798

Krizek, 2001, Clinical application of a rapid method using agarose gel electrophoresis and Western blotting to evaluate von Willebrand factor protease activity, Electrophoresis, 22, 946, 10.1002/1522-2683()22:5<946::AID-ELPS946>3.0.CO;2-U

Krizek, 2000, A rapid method to visualize von Willebrand factor multimers by using agarose gel electrophoresis, immunolocalization and luminographic detection, Thromb Res, 97, 457, 10.1016/S0049-3848(99)00196-6

Tsai, 1998, Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura, N Engl J Med, 339, 1585, 10.1056/NEJM199811263392203

Fujikawa, 2001, Purification of human von Willebrand factor-cleaving protease and its identification as a new member of the metalloproteinase family, Blood, 98, 1662, 10.1182/blood.V98.6.1662

Girma, 1986, Limited proteolysis of human von Willebrand Factor by staphylococcus aureus V-8 protease, Biochemistry, 25, 3156, 10.1021/bi00359a013

Gerritsen, 1999, Assay of von Willebrand factor (VWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF—A tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP), Thromb Haemost, 82, 1386, 10.1055/s-0037-1614780

Aronson, 2001, A rapid assay for the vWF protease, Thromb Haemost, 85, 184, 10.1055/s-0037-1612926

Rick, 2002, Clinical use of a rapid collagen binding assay for von Willebrand factor cleaving protease in patients with thrombotic thrombocytopenic purpura, Thromb Haemost, 88, 598, 10.1055/s-0037-1613262

Schneppenheim, 2003, von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP, Blood, 101, 1845, 10.1182/blood-2002-08-2399

Bohm, 2002, Evaluation and clinical application of a new method for measuring activity of von Willebrand factor-cleaving metalloprotease (ADAMTS13), Ann Hematol, 81, 430, 10.1007/s00277-002-0502-3

Yoo, 2003, Decreased levels of von Willebrand factor-cleaving protease in coronary heart disease and thrombotic thrombocytopenic purpura, Br J Haematol, 121, 123, 10.1046/j.1365-2141.2003.04257.x

Kinoshita, 2001, Upshaw-Schulman syndrome revisited, Int J Hematol, 74, 101, 10.1007/BF02982558

Obert, 1999, Estimation of the von Willebrand factor-cleaving protease in plasma using monoclonal antibodies to vWF, Thromb Haemost, 82, 1382, 10.1055/s-0037-1614779

Veyradier, 2001, Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies, Blood, 98, 1765, 10.1182/blood.V98.6.1765

Furlan, 1998, Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura, Blood, 91, 2839, 10.1182/blood.V91.8.2839.2839_2839_2846

Kasper, 1975, Proceedings, Thromb Diath Haemorrh, 34, 612

Tsai, 2001, Inhibitors of von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura, Clin Lab, 47, 387

Park, 2002, Impaired activity of plasma von Willebrand factor-cleaving protease may predict the occurrence of hepatic veno-occlusive disease after stem cell transplantation, Bone Marrow Transplant, 29, 789, 10.1038/sj.bmt.1703544

Mori, 2002, Predicting response to plasma exchange in patients with thrombotic thrombocytopenic purpura with measurement of vWF-cleaving protease activity, Transfusion, 42, 572, 10.1046/j.1537-2995.2002.00100.x

Studt, 2003, Measurement of von Willebrand factor-cleaving protease (ADAMTS-13) activity in plasma, J Thromb Haemost, 1, 1882, 10.1046/j.1538-7836.2003.00385.x